Last reviewed · How we verify
NCT03458299
Strategies: Motivational Interviewing/Psychoeducation
NA trial testing Motivational Interviewing in Alcohol Use, Underage in 75 participants. Completed in 9 February 2022.
9 February 2022
Quick facts
| Lead sponsor | Pacific Institute for Research and Evaluation |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 75 |
| Start date | 23 January 2018 |
| Primary completion | 9 February 2022 |
| Estimated completion | 9 February 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Motivational Interviewing
- Psychoeducation
Conditions studied
- Alcohol Use, Underage — all drugs for Alcohol Use, Underage →
- Substance Use — all drugs for Substance Use →
- Underage Drinking — all drugs for Underage Drinking →
Sponsor
Pacific Institute for Research and Evaluation
Who can join
Adults 13 to 20, any sex, with Alcohol Use, Underage or Substance Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this research program is to implement and evaluate complementary interventions designed to address underage alcohol, marijuana, tobacco and other drug use and abuse among Native American youth residing in and around nine contiguous Indian reservations in rural portions of a Southern California county. Component 1. Motivational Interviewing (MI) Evaluations (Identified PHI). Approximately 150 participants between 13 and 20 years of age will participate in the Motivational Interviewing (MI) intervention and one follow-up assessment over an 18 month period. Questionnaires of youth substance use and access patterns will be by phone or self-administered using paper, iPad, and web-based surveys. Formal informed consent from participants 18 and older and assent and parental/legal guardian consent will be obtained from those participants under 18. Component 2. Psychoeducation (PE) Evaluations (Identified PHI). Approximately 150 participants between 13 and 20 years of age will participate in the Psychoeducation (PE) intervention and one follow-up assessment over an 18 month period. Questionnaires of youth substance use and access patterns will be by phone or self-administered using paper, iPad, and web-based surveys. Formal informed consent from participants 18 and older and assent and parental/legal guardian consent will be obtained from those participants under 18.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03458299
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Motivational Interviewing
Trials testing the same drug.
- NCT07218471 — Cannabis Reduction and Functional Outcomes · NA · recruiting
- NCT07415707 — The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in N · NA · recruiting
- NCT07364773 — Enhancing Rehabilitation Participation in Patients With SCI/D Using Motivational Interviewing · NA · recruiting
- NCT07169955 — The Effect of Motivational Interviewing on Patients With Lumbar Discectomy · NA · completed
- NCT06852664 — Improving Activity in Individuals With Cerebral Palsy · NA · recruiting
Other Pacific Institute for Research and Evaluation trials
Trials by the same sponsor.
- NCT05383755 — Digital Intervention to Address Stigma Among Pregnant Adolescents Living With HIV · NA · completed
- NCT03550404 — Improving Native American Elder Access to and Use of Healthcare · completed
- NCT04067804 — Implementing Restorative Practices for Youth · NA · terminated
- NCT03652688 — Group-based Intervention for Club Patrons · NA · completed
- NCT03521115 — Family Based Prevention of Alcohol and Risky Sex for Older Teens · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03458299 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pacific Institute for Research and Evaluation
- Last refreshed: 17 March 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03458299.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing